I'll analyze the JD Sports filings and produce the research note.

JD Sports Fashion PLC (JD.) — Investment Research Note

Executive summary

JD Sports Fashion is a global omni-channel sports fashion retailer operating 4,811 stores across 36 countries under fascias including JD, Hibbett, Courir, DTLR and Shoe Palace, with 38% of sales in North America, 33% in Europe and 25% in the UK. Across the period covered, the business scaled aggressively (2021 revenue £6.2bn → FY26 £12.7bn) through acquisitions (Shoe Palace, DTLR, Hibbett, Courir) while like-for-like sales weakened in FY26 (-2.1%) and operating margins compressed 120bps to 7.0% under a tough consumer backdrop and a softer footwear product cycle. The single most important point for valuation today: the stock trades on ~8x FY26 adjusted EPS and ~10% free-cash-flow yield with net cash before leases and a £200m rolling buyback — a cheap, cash-generative FTSE 100 retailer whose main "why so cheap" is muted market growth and dependence on brand-partner (chiefly Nike) product cycles.

Fair value estimate

• Fair value range: 105–135p per share (implied market cap £5.0bn–£6.4bn)
• Methodology: blended forward P/E (8–11x FY27 adjusted EPS) cross-checked against free-cash-flow yield (7–9%)
• Key assumptions: FY27 PBTAI at guidance midpoint of £800m (mid of £750–850m guided range) 2026-05 FY26 results; effective tax rate ~24.8%; NCI ~£35m; FCF ~£490m midpoint of £460–520m guidance. This produces adjusted EPS ~11–12p on a reducing share count from the rolling £200m buyback. Applying 9–11x forward P/E (below UK large-cap retail median given cyclical exposure and low visibility) gives 100–130p. Cross-checking on FCF: £490m at 7–9% target FCF yield = £5.4bn–£7.0bn EV, less ~£800m Genesis put option liability = £4.6–6.2bn equity value, or ~95–130p per share. Blended range 105–135p.
• Vs latest disclosed market cap of £4,544m: fair-value midpoint £5.7bn implies ~26% upside to current ~£4.5bn; range spans +10% to +40%.

Sector context

Consumer Discretionary / Retail (ICB Super-Sector). JD sits at the premium end of global sports-fashion retail with a heavy dependence on the multi-year athleisure/sneaker trend and brand-partner product cycles. Quality is above sector median (best-in-class relationships with Nike/adidas, global scale, strong FCF conversion); growth is in line to below (LFL negative, muted market outlook); leverage is below typical peers (net cash before leases; 1.4x incl. leases). Listed peers: Foot Locker (US), Dick's Sporting Goods (US), Frasers Group (UK). JD is closer to Foot Locker in scale and exposure but has a better balance sheet and higher gross margin.

Investment thesis (3 bullets)

• Cheap on cash: FCF has stepped up materially and management has committed to shareholder returns. FY26 FCF was £462m (+36% YoY) and FY27 guidance is £460–520m, with a 3-year cumulative >£1.4bn target FY26–FY28 2026-05 FY26 results. A rolling £200m annual buyback plus a 20% dividend uplift underpins ~5–6% capital-return yield at the current price against a c.10% FCF yield.
• North America — largest region — turned positive in Q4 FY26 and momentum improving. NA LFL returned to growth in peak Q4 FY26 (+1.5% LFL, +5.3% organic) after a full-year -1.8%, supported by Finish Line-to-JD conversions and a re-platformed US e-commerce site, with US-JD brand awareness materially higher YoY 2026-01 Q4 update, 2026-05 FY26 results. The strategic pivot to focus on JD-brand-first with 174 remaining Finish Line stores available for conversion gives multi-year self-help.
• Genuine balance-sheet quality provides downside protection. Net cash before lease liabilities of £311m at Jan 2026 (up from £52m); £1.8bn total liquidity; a refinanced £1bn RCF to 2030 and $700m term loan to 2028 with investment-grade-style leverage of 1.4x on lease-inclusive net debt (1.9x including the Genesis put) 2026-05 FY26 results. This is unusual for a global retailer.

Key risks (3 bullets)

• Consumer softness and continued LFL declines. Q1 FY27 organic flat, LFL -2.3%, with April volatile. Management explicitly guided to "muted market growth" in FY27 and widened the profit range (£750–850m vs FY26 £852m) 2026-05 FY26 results. If the consumer softens further, PBTAI could land below the range, and operating deleverage on a heavier lease base would bite hard.
• Nike concentration / footwear product-cycle risk. Multiple filings cite "end-of-cycle" product headwinds in key footwear lines; the business is disproportionately exposed to Nike/Jordan innovation and any prolonged brand slowdown compresses gross margin and LFL 2025-11 Q3 update, 2026-05 FY26 results. Historical FY24-25 US promotional intensity showed how quickly margins can move against JD.
• Non-cash-heavy adjusting items and £787m Genesis put liability create noise. FY26 statutory PBT of £629m vs adjusted £852m; £223m of adjusting items (impairments £119m, amortisation of acquired intangibles £69m, put/call remeasurements). The Genesis put/call to acquire the remaining 20% of the North American sub-group is exercisable 2029/2030 and capped at £1.46bn — a material future cash outflow that constrains capital-return capacity later this decade 2026-05 FY26 results.

Operating leverage

JD's cost base is dominated by variable/semi-variable retail costs (staff, rent recognised as lease costs, occupancy, marketing), but the platform investments (Heerlen automation, US Morgan Hill DC, e-commerce re-platforming, "£20m+ of double-running cost unwind across FY27-28") create genuine fixed-cost leverage over the medium term. FY26 gross margin was 47.0% flat; operating margin (post lease interest) is 7.0% and the historic peak was ~10%. Fixed costs (central, tech, DC network) are a modest but growing share; the last major deleveraging event (FY26 LFL -2.1%) drove -120bps of operating margin, implying incremental sales at c. 20-30% contribution margin. A 10-15% upside surprise to FY27 revenue (from stronger footwear cycle or NA momentum) plausibly adds 100-150bps of margin and lifts PBTAI 20-35% — meaningful but not the "multiples of profit" operating leverage the strategy prizes. The unwind of dual-running distribution costs in Europe (£20m+ across FY27-28) is a modest self-help kicker 2026-05 FY26 results, 2025-09 H1 results.

Value-trap signals

• LFL sales negative in FY24, FY25 and FY26 despite acquisition-driven top-line growth
• PBTAI down from £947m (FY22) to £923m (FY25) to £852m (FY26) to guided £750–850m (FY27) — a multi-year earnings decline
• Repeated downward guidance revisions during FY26 (from >£900m consensus in Sept 2025 to £849m by January 2026 to actual £852m; FY27 range widened at May 2026)
• Concentrated dependence on Nike/adidas product cycles that management cannot control
• Ongoing CMA regulatory noise (US employment litigation £14m provision, historic Rangers/Leicester investigations)
• Deferred but material Genesis put/call liability (~£787m) crystallising in FY30/FY31

Earnings vs expectations

• FY26 (May 2026): delivered PBTAI £852m vs the Jan 2026 guided "lower end of £849m consensus range" — met the revised guidance but this was the third narrowing of expectations through the year.
• Q3 FY26 (Nov 2025): guided to "lower end of £871m consensus" — a de facto miss vs H1 expectations of £878m consensus.
• H1 FY26 (Sep 2025): in line with revised August guidance of £351m; had cut from the earlier expectation implicit in the FY25 print.
• FY25 (May 2025): PBTAI in line with the revised £915-935m guided range from January 2025 (which itself had been cut mid-year).
• Pattern: management has consistently guided in-line-with-revised-consensus after cutting from initial expectations. It's "meet-after-cut" more than "beat" — closer to repeated shallow misses relative to the start-of-year plan. FY22 was the last unambiguous beat.

Conviction

Conviction: 3 (moderate). What anchors it: (i) clean, well-audited disclosure with detailed segmental splits and reconciliations; (ii) FCF is real and above-line profit, cross-checkable to buyback/dividend cash flows; (iii) balance sheet is genuinely strong. What limits it: (i) FY27 PBTAI range is unusually wide (£750-850m) reflecting management's own uncertainty about consumer/brand-cycle timing; (ii) the Genesis put/call adds a large, non-linear liability that most simple valuations mishandle; (iii) the multi-year LFL decline makes "normalised" earnings hard to fix.

Driver scoring rationale

• ai_beneficiary (low): JD is a spender on AI (loyalty personalisation, discoverability optimisation for agentic AI shopping like ChatGPT/Gemini), not a recipient of AI capex flows. Filings mention "accelerating AI adoption" as a strategic priority 2026-05 FY26 results but this is defensive positioning; if anything, agentic shopping platforms could disintermediate multi-brand retailers over the long term.
• operating_leverage (moderate): Retail cost base is mostly variable/semi-variable; fixed cost element (DCs, tech, central) is real but modest. FY26 -2.1% LFL drove -120bps margin, a c.20-30% contribution margin on incremental sales.
• earnings_surprise_trend (below par): Repeated intra-year guidance cuts in FY24, FY25 and FY26; consistently "met-after-cut" rather than beats.
• cyclicality (moderate-high): Discretionary youth apparel/footwear tied to consumer confidence and product-cycle innovation.
• moat (moderate): Long-standing Nike/adidas partnerships and global scale create real barriers, but retail moats erode faster than industrial ones and brand DTC is a structural threat.
• leverage (low): Net cash before leases; 1.4x on lease-inclusive basis; investment-grade parameters.
• earnings_quality (medium): Large adjusting items each year (£223m in FY26, £208m FY25) but FCF conversion is genuinely strong and the adjustments are well disclosed.
• management_quality (competent): Régis Schultz has executed disciplined strategy since 2022; Hibbett integration on track; capital allocation now more shareholder-friendly. Historic governance issues (2022) fully addressed.
• growth_momentum (weak): Organic sales +2.1% FY26 but LFL -2.1% for third consecutive year; FY27 guided to muted market and profit decline.

Overall score rationale

This is a "right idea, wrong receiver" for an AI-focused portfolio. JD scores badly on the dominant AI-beneficiary criterion (~35% weight) — it's not a picks-and-shovels name and could face medium-term disintermediation from agentic shopping. Operating leverage is moderate rather than the "multiples-of-profit" long-tail the strategy seeks. What lifts the score above the bottom bucket: the valuation is genuinely cheap (P/E ~8x, FCF yield ~10%), the balance sheet is fortress-quality, and there is real fair-value support 15-30% above current price. This gives good downside protection and a modest positive expected return, but doesn't fit the "AI-receiver with operating leverage" thesis. Overall: partial-fit / low-to-medium band.